Literature DB >> 16476879

C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease.

Alexandros C Makis, Eleftheria C Hatzimichael, Justin Stebbing, Konstantinos L Bourantas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16476879     DOI： 10.1001/archinte.166.3.366

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

1.  Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.

Authors:  Carolyn Hoppe; Eufemia Jacob; Lori Styles; Frans Kuypers; Sandra Larkin; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2017-03-28       Impact factor: 6.998

2.  Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

Authors:  Madhan Thamilarasan; Rodolfo Estupinan; Ines Batinic-Haberle; Rahima Zennadi
Journal:  Blood Adv       Date:  2020-06-09

3.  A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.

Authors:  Carolyn Hoppe; Frans Kuypers; Sandra Larkin; Ward Hagar; Elliott Vichinsky; Lori Styles
Journal:  Br J Haematol       Date:  2011-04-08       Impact factor: 6.998

4.  Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

Authors:  Suba Krishnan; Yamaja Setty; Suhita G Betal; Vaidyula Vijender; Koneti Rao; Carlton Dampier; Marie Stuart
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

5.  Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein.

Authors:  Kehinde Sola Akinlade; Adedeji David Atere; John Ayodele Olaniyi; Sheu Kadiri Rahamon; Christiana Odunayo Adewale
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.